cgt logo

All Content

Find all the latest content right here and navigate through all resources

Designing a robust supply chain for ATMPs

In this interview, Lars Krosch, VP Sales at time:matters gives his perspective on the following:
  • How thorough supply chain planning can speed up the vein-to-vein process without increasing the risk
  • The importance of an agile supply chain
  • The value of full supply chain transparency and tracking is in the physical accessibility of the shipment
  • When to involve handling agents and airlines in your supply chain design

 

Read more


 

Top 15 Cell and Gene Therapy Biotechs

The pace of innovation across cell and gene therapy biotechs is gaining speed and it can be challenging to keep track of scientific developments, new technologies and who’s looking for their next big partnership. So, we’re keeping tabs on the innovators and disruptors for you.

Download the ebook


 


 


 

Regenerative Medicine CMO's in Japan

There are currently ten noteworthy regenerative medicine CMOs in operation in Japan. Most service providers focus on the PMD. Act route to market, but a few also provide services for those looking to enter the market under the ASRM route....

Find out more


 


 

Towards the $1000 Therapy - Richard Grant

Richard Grant, Global VP, Cell Therapy, Invitech presents "Towards the $1000 Therapy". Watch the presentation where Richard talk about the importance of supply chain when trying to deliver therapies to patients at a more affordable cost....

Find out more 


 

Viral Safety for ATMPs Part 1

Over the past few decades, many lessons have been learnt by the wider biological medicinal product community when it comes to preventing transmission of viral infections. The World Federation of Haemophilia’s mantra...

Read more


 


 

More content coming soon! 

Check back regularly to catch up with the latest content, or   sign up to our e-newsletter here to receive it directly into your inbox every month.

Discover Content by Topic

  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK